KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Payables (2016 - 2025)

Historic Payables for Novavax (NVAX) over the last 17 years, with Q3 2025 value amounting to $15.2 million.

  • Novavax's Payables fell 7352.61% to $15.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.2 million, marking a year-over-year decrease of 7352.61%. This contributed to the annual value of $41.6 million for FY2024, which is 6864.57% down from last year.
  • Novavax's Payables amounted to $15.2 million in Q3 2025, which was down 7352.61% from $50.6 million recorded in Q2 2025.
  • In the past 5 years, Novavax's Payables registered a high of $710.7 million during Q2 2022, and its lowest value of $15.2 million during Q3 2025.
  • Moreover, its 5-year median value for Payables was $87.2 million (2023), whereas its average is $175.7 million.
  • Its Payables has fluctuated over the past 5 years, first skyrocketed by 441171.56% in 2021, then plummeted by 8772.32% in 2023.
  • Quarter analysis of 5 years shows Novavax's Payables stood at $127.0 million in 2021, then skyrocketed by 326.13% to $541.4 million in 2022, then crashed by 75.51% to $132.6 million in 2023, then tumbled by 68.65% to $41.6 million in 2024, then plummeted by 63.38% to $15.2 million in 2025.
  • Its Payables was $15.2 million in Q3 2025, compared to $50.6 million in Q2 2025 and $34.2 million in Q1 2025.